The latest advances in the clinical translation of cell therapy for stroke sequelae and Parkinson''s diseaseOA
Recently,two major developments have been reported regarding the clinical translation of cell therapy for neurodegenerative and neurological damage-related diseases in the field of Neurorestoratology.First,olfactory ensheathing cells(OECs)were approved for clinical application in the treatment of patients wit h stroke sequel and Parkinson''s disease(PD)in China on February 11,2026.1 Second,Amchepry(allogeneic induced pluripotent stem cell[iPSC]-derived dopaminergic progenitors).
Hongyun Huang
Department of Neurorestoratology,Brain Hospital,First Affiliated Hospital of Henan Medical University,Xinxiang 453100,China Department of Neurorestoratology,Taian Central Hospital,Taian 271000,China
医药卫生
olfactory ensheathing cellsclinical translationstroke sequelaecell therapydopaminergic progenitorsParkinsons diseaseallogeneic induced pluripotent stem cell derived dopaminergic progenitorsneurorestoratologyfirstolfactory ensheathing cells oecs
《Journal of Neurorestoratology》 2026 (4)
P.1-2,2
评论